Which Institutions Own Shares In Arbutus Biopharma Corp (ABUS)?
Arbutus Biopharma Corp (NASDAQ: ABUS) is 9.20% higher on its value in year-to-date trading and has touched a low of $1.69 and a high of $3.29 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will […]
Why should you keep an eye on Arbutus Biopharma Corp (ABUS)?
Arbutus Biopharma Corp (NASDAQ: ABUS) is 23.60% higher on its value in year-to-date trading and has touched a low of $1.69 and a high of $3.29 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will […]
Who are the Institutional Holders in Arbutus Biopharma Corp (ABUS)?
Arbutus Biopharma Corp (NASDAQ: ABUS) is 20.00% higher on its value in year-to-date trading and has touched a low of $1.69 and a high of $3.25 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will […]
Who are the Institutional Holders in Arbutus Biopharma Corp (ABUS)?
Arbutus Biopharma Corp (NASDAQ: ABUS) is 4.00% higher on its value in year-to-date trading and has touched a low of $1.69 and a high of $3.14 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will […]
